MND and Continence: Understanding the Link and Managing It Well
For many people living with Motor Neurone Disease, bladder and bowel changes are significant but rarely discussed. Here is what the research tells us, and how the right clinical support and products can make a genuine difference.
How MND Affects Bladder and Bowel Function
Motor Neurone Disease (MND) is a progressive neurological condition affecting the motor neurons that control voluntary muscle movement. While mobility, speech and respiratory decline are well-documented features of the disease, the impact on bladder and bowel function is frequently underestimated in both clinical and community settings.
The connection between MND and continence operates through two distinct pathways; direct neurological disruption, and the functional and physical barriers that emerge as the disease progresses. Understanding both is essential to building a care plan that actually meets the person's needs.
What the Research Tells Us
Research published in the Journal of Neurology, Neurosurgery and Psychiatry has identified urinary urgency, frequency and incomplete bladder emptying as symptoms that can present across different stages and subtypes of MND. Historically these symptoms were considered uncommon, but more recent research reflects a meaningfully higher prevalence than was previously documented.
Where MND overlaps with frontotemporal dementia (FTD); an occurrence in an estimated 10 to 15 percent of cases; the frontal lobe regions responsible for suppressing bladder urgency may be directly affected. In these cases, urgency incontinence is neurogenic rather than functional in origin and requires a different clinical approach.
Bowel dysfunction, particularly constipation, is among the most consistently reported non-motor symptoms in MND. Contributing factors include reduced physical activity, declining fluid intake due to dysphagia, medication effects (particularly anticholinergic agents used for saliva management), and loss of abdominal muscle strength required for effective defecation.
Physical and Environmental Barriers
Even where the neurological continence pathways remain intact, MND introduces significant practical barriers to self-management.
Key contributing factors in MND-related continence challenges
-
Progressive limb weakness reduces independence in reaching the bathroom; particularly at night when falls risk is highest.
-
Upper limb weakness affects the ability to manage clothing fastenings, personal hygiene, and continence product application and removal.
-
Fatigue; reported by the majority of people with MND; compounds all of the above and reduces the margin for managing urgency safely.
-
Reduced fluid intake due to dysphagia concentrates urine, increases bladder irritability, and elevates urinary tract infection risk.
-
Respiratory muscle involvement makes voluntary "holding on" increasingly difficult as intra-abdominal pressure becomes harder to regulate.
-
Home environment factors; bathroom proximity, door widths, toilet height, grab rail placement; directly affect continence management capacity.
Incontinence-Associated Dermatitis: A Critical Risk
People living with MND face a significantly elevated risk of incontinence-associated dermatitis (IAD) due to the combination of moisture exposure and reduced capacity to reposition. Skin in prolonged contact with urine or stool can break down rapidly; particularly over bony prominences; and once established, IAD can progress to more serious skin and wound complications.
Clinical guidance consistently supports a structured skin care protocol from the point of diagnosis rather than after skin breakdown occurs. This includes pH-balanced skin cleansers, barrier creams or films, and appropriate continence product selection to minimise contact time and promote skin breathability.
Early signs of IAD to monitor
- Redness, warmth or tenderness in skin covered by products
- Burning, stinging or itching sensation
- Skin that looks wet, shiny or macerated
- Shallow skin breaks or erosions
When to escalate
- Broken or weeping skin not responding to barrier products
- Signs of infection; heat, swelling, odour or fever
- Wound not healing within expected timeframe
- Increasing pain beyond what product adjustment resolves
Products That Support MND Continence Care
Product needs in MND typically evolve across the disease trajectory. A continence assessment that captures the full picture allows for a product plan that can flex as needs change; reducing waste and carer frustration over time. Both disposable and reusable products play a role, and the right combination depends on the individual's stage, routine, and carer capacity.
Disposable Briefs, Pants and Pads
Disposable continence products offer a high-absorbency, single-use solution suited to a range of MND stages. As mobility and upper limb strength decline, open-style tab briefs become easier for carers to manage without requiring the person to stand. Pull-up style pants suit earlier stages where independence is still maintained.
- Tab-style open briefs for carer-assisted changes
- Pull-up pants for moderate independence
- Shaped pads for lighter urinary urgency
- Heavy and overnight absorbency options available
Washable Absorbent Underwear and Pads
Washable continence products can complement a disposable routine; particularly for people in earlier stages of MND who prefer a more discreet everyday option, or for use as a backup layer for added security. Breathable and designed to look and feel like regular underwear.
- Comfortable and discreet for everyday wear
- Suitable for light to moderate urinary leakage
- Can be used alongside disposables for added confidence
- Washable bed pads also available for nighttime protection
Barrier Creams, Cleansers and Skin Protection
Purpose-formulated skin care is essential for anyone with reduced mobility and prolonged product contact. A structured routine using pH-balanced cleansers and barrier products significantly reduces IAD risk and supports skin integrity over the course of the disease. Products include Sage Comfort Shield Barrier Cream Cloths for efficient cleansing during changes.
- pH-balanced cleansers safe for frequent use
- Barrier creams and films for moisture protection
- All-in-one barrier cloths for carer efficiency
- Suitable for sensitive and compromised skin
Waterproof Mattress Protectors and Bed Pads
Protecting the sleep surface reduces nighttime change frequency and supports both the person with MND and their carer. Waterproof mattress protectors and layered bed pads are typically introduced early and remain a key part of the care plan throughout the disease trajectory.
- Quiet and breathable waterproof mattress protectors
- Disposable and washable bed pad options
- High-absorbency overnight protection
- Reduces frequency of full bedding changes
Oral Nutritional Supplements
Dysphagia in MND significantly reduces both fluid and dietary fibre intake; two key factors in bowel regularity. Oral nutritional supplements provide concentrated nutrition in low-volume, modified-texture formats that support bowel function, weight maintenance and overall health alongside medical management.
- High-calorie, low-volume formats for dysphagia
- Supports bowel regularity and fibre intake
- Range includes Fortisip and equivalent products
- Suitable for NDIS funding under consumables
Catheters, Drainage Bags and Urology Supplies
For advanced MND where urinary retention or catheterisation becomes clinically appropriate, a full range of urology and drainage products is available. Clinical guidance from a continence nurse or urologist is recommended before commencing catheter management.
- Urinary catheters and drainage bags
- Catheter securing tape and fixation products
- Uridomes for male urinary management
- NDIS-fundable under consumables with appropriate assessment
Getting the Right Assessment for NDIS Funding
For NDIS participants, a formal continence assessment conducted by a qualified continence nurse or relevant clinician is the primary mechanism for accessing funding for continence products under the Core Supports: Consumables budget. The report produced must clearly link continence needs to the participant's disability and demonstrate that recommended supports are reasonable and necessary.
In MND specifically, needs can shift quickly as the disease progresses. A well-written assessment will not only capture current requirements but also anticipate likely changes; reducing the need for urgent reassessment and plan amendments at short notice. Support coordinators and plan managers are encouraged to initiate assessment conversations well ahead of plan review dates.
Signs it is time for a continence review in MND
-
✓Current products are leaking or no longer managing output effectively
-
✓Skin irritation or breakdown has appeared or worsened
-
✓Mobility or upper limb function has changed significantly
-
✓Carer management of product changes has become difficult or unsafe
-
✓NDIS plan review is approaching and current funding no longer reflects actual product use
-
✓A new medication has been introduced that may affect bladder or bowel function
Need help finding the right products or support?
Our team is here to help you navigate the right continence solutions for MND; across disposables, skin care, bed protection, nutrition, and more.
Shop All ProductsReferences and Sources
- MND Australia. (2024). About MND: Facts and Statistics. Retrieved from mndaust.asn.au
- Continence Foundation of Australia. (2023). Neurogenic Bladder and Bowel Fact Sheet. Retrieved from continence.org.au
- Noto Y, Shiga K, Tsuji Y, et al. (2012). Autonomic nervous system dysfunction in amyotrophic lateral sclerosis. Journal of Neurology, Neurosurgery and Psychiatry.
- Lillo P, Mioshi E, Burrell JR, Kiernan MC, Hodges JR, Hornberger M. (2012). Grey and white matter changes across the ALS-FTD spectrum. PLOS ONE.
- Greenway MJ, Leigh PN, Hardiman O. (2006). Bowel dysfunction in amyotrophic lateral sclerosis. Amyotrophic Lateral Sclerosis.
- National Disability Insurance Agency (NDIA). (2024). Continence Products and NDIS Funding Guidelines. Retrieved from ndis.gov.au
- Australian Commission on Safety and Quality in Health Care. (2022). Preventing and Managing Incontinence-Associated Dermatitis: Clinical Guidelines.
This article is intended as general clinical and educational information only and does not replace advice from a qualified healthcare professional. References should be verified prior to publication. Product recommendations should be guided by a formal continence assessment where possible.